11-64805718-C-T
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM1PM2PM5PP2PP3_ModeratePP5_Moderate
The NM_001370259.2(MEN1):c.1102G>A(p.Ala368Thr) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A368V) has been classified as Uncertain significance.
Frequency
Consequence
NM_001370259.2 missense
Scores
Clinical Significance
Conservation
Publications
- multiple endocrine neoplasia type 1Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet, Ambry Genetics
- familial isolated hyperparathyroidismInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- pituitary gigantismInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary pheochromocytoma-paragangliomaInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MEN1 | NM_001370259.2 | c.1102G>A | p.Ala368Thr | missense_variant | Exon 8 of 10 | ENST00000450708.7 | NP_001357188.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.A368T variant (also known as c.1102G>A), located in coding exon 7 of the MEN1 gene, results from a G to A substitution at nucleotide position 1102. The alanine at codon 368 is replaced by threonine, an amino acid with similar properties. The p.I360F variant (also known as c.1078A>T), located in coding exon 7 of the MEN1 gene, results from an A to T substitution at nucleotide position 1078. The isoleucine at codon 360 is replaced by phenylalanine, an amino acid with highly similar properties. The p.R355Q variant (also known as c.1064G>A), located in coding exon 7 of the MEN1 gene, results from a G to A substitution at nucleotide position 1064. The arginine at codon 355 is replaced by glutamine, an amino acid with highly similar properties. The p.A368T, p.I360F and p.R355Q variants have been observed in cis in individuals with features consistent with multiple endocrine neoplasia type 1 (Ambry internal data). These amino acid positions are highly conserved in available vertebrate species. In addition, these variants are predicted to be deleterious by in silico analysis. These variants are considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the majority of available evidence to date, the p.A368T, p.R355Q and p.I360F variants are interpreted as a likely pathogenic haplotype. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at